Mitochondrial heterogeneity drives the evolution of fungicide resistance in <i>Phytophthora sojae</i>, with associated fitness trade-offs.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41576162.
- Also identified by DOI 10.1126/sciadv.adz4601 and PMC identifier 12829574.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mitochondrial complex III inhibitors, such as ametoctradin, are crucial for controlling oomycete diseases. However, the increasing severity of fungicide resistance necessitates urgent clarification of its evolutionary mechanisms to optimize disease management and delay resistance development. The DddA-derived cytosine base editors (DdCBEs)-mediated base editing in oomycetes confirmed that the <i>PsCytb</i><sup>S33L</sup> mutation is sufficient to confer ametoctradin resistance in <i>Phytophthora sojae</i>. We clarified that low-resistant and medium-resistant mutants serve as transitional populations during the resistance evolution process, with high-resistant mutants eventually becoming the dominant population. We revealed the dynamic changes in mitochondrial heterogeneity under fungicide selection, proving that the gradual increase of mutated mitochondria drives resistance evolution. There is a trade-off between ametoctradin resistance and fitness. While the <i>PsCytb</i><sup>S33L</sup> mutation confers this resistance, it impairs mitochondrial function and thereby reduces fitness. Up-regulation of <i>TFAM1</i>, however, can partially offset this fitness cost. Resistance evolution in plant pathogens involves not only standing variation but also de novo mutations, providing unique insights into the "chicken-and-egg" dilemma.
Medical subject headings
- Phytophthora
- Mitochondria
- Fungicides, Industrial
- Genetic Fitness
- Drug Resistance, Fungal